As demand for GLP-1 receptor agonists (GLP-1RAs) surges, fragmented prescribing practices threaten patient safety. A ...
Clinical trials that rely on subjective or semi-subjective endpoints, such as clinician-reported outcomes or patient-reported symptoms, face distinct challenges when it comes to data integrity.